ABSTRACT Motivations and
INTRODUCTION
Current DNA chip-based technologies (Schena et al., 1995; Lockhart et al., 1996; Velculescu et al., 1995) can measure the expression level of thousands of genes simultaneously, generating a large amount of high-dimensional data. It is of great interest to analyze the data and to extract comprehensible patterns. Based on the concept of emerging patterns (Dong and Li, 1999) , this work is aimed at discovering special gene groups from the * To whom correspondence should be addressed. ALL/AML dataset (Golub et al., 1999) and the colon tumor dataset (Alon et al., 1999) . The discovered patterns consist of groups of genes that are constrained to specific intervals of gene expression levels such that these patterns only occur in one class of cells but do not occur in the other cells. In other words, these patterns correspond to the conditions on gene expression levels that dominate that class of cells. Then pharmacological intervention may be introduced based on these patterns to modulate the expression levels of some genes to treat a disease.
Emerging patterns (Dong and Li, 1999 )-EPs for short-are an important concept used in this paper. EPs capture significant differences between two classes of things, such as edible mushrooms vs poisonous mushrooms, normal tissues vs cancer tissues, and so on. The significance of the differences is measured by the magnitude of the frequency-change ratio of the patterns from one class to another. The larger the frequency-change ratio, the more important the patterns. Due to the sharp change in frequency, EPs can be used to distinguish instances between different classes and to predict the class label of new instances. For example the following EP, {gene(K 03001) ≥ 89.20} and {gene(R76254) ≥ 127.16} and {gene(D31767) ≥ 63.03} discovered from the colon tumor dataset later, changes its frequency of 0% in normal tissues to a frequency of 75% in cancer tissues. Here gene(X ) represents the expression level of the gene X . According to this emerging pattern, if the expression levels of K03001, R76254, and D31767 in a new cell experiment are, respectively, not less than 89.20, 127.16, and 63.03 , then this cell is much more likely a cancer cell. Gene expression data are typically organized as a matrix. Assume that such a matrix has n rows and m columns. Then n usually represents the number of considered genes and m the number of experiments. The experiments are mainly categorized into two types. The first type of experiments are aimed at simultaneously monitoring the n genes m times under a series of varying c Oxford University Press 2002 conditions (Chu et al., 1998; DeRisi et al., 1997; Roberts et al., 2000; Wen et al., 1998) . The second type is used to examine the n genes in a single environment but from m different cells (Alon et al., 1999; Golub et al., 1999; Perou et al., 1999; Wang et al., 1999; Zhu et al., 1998) . The first type of experiments are intended to detect trends and regularities of the expression of every single gene under a series of conditions. The resulting data are generally temporal. The latter type of experiments are expected to provide information for classifying the type of new cells and for identifying useful genes whose expressions are good diagnostic indicators (Alon et al., 1999; Golub et al., 1999) . The resulting data are generally spatial.
The colon tumor dataset (Alon et al., 1999) and the ALL/AML dataset (Golub et al., 1999) were obtained by conducting the second type of experiments. The colon tumor dataset consists of 22 normal tissues and 40 colon tumor tissues. The ALL/AML dataset consists of 38 bone marrow samples obtained from acute leukemia patients; 27 of them are acute leukemias arising from lymphoid precursors (acute lymphoblastic leukemia, ALL), and the remaining 11 cases are acute leukemias arising from myeloid precursors (acute myeloid leukemia, AML).
We investigate the problems below: (i) Which intervals of the expression levels of a group of genes occur only in cancer tissues but not in the normal tissues and vice versa, or only in ALL patients but not in AML patients and vice versa? (ii) How to discretize a range of the expression levels of each gene into multiple intervals so that the contrasting intervals, which form our EPs, are informative and reliable? (iii) How to explain the results and then to suggest a plan for treating the disease?
We approach these problems using several techniques. First, we use an entropy-based discretization method (Fayyad and Irani, 1993) to discretize gene expression levels into suitable intervals. This method partitions a range of real values into a number of disjoint intervals such that the entropy of the partition is minimal. The selection of cut points, breaking points in a range, in this discretization process is crucial. With the minimal entropy idea, the intervals are 'maximally' discriminatory between expression values from normal cells and expression values from cancer cells. This method automatically ignores those ranges which contain uniformly mixed normal and cancer cells' expression values. For the colon cancer dataset, of its 2000 genes, only 35 genes are discretized into 2 intervals. The remaining 1965 genes are ignored by the method. This result is very important because it implies that most of the genes are viewed as irrelevant by the method. It gives us an easy platform where a small number of good diagnostic indicators are concentrated. Second, we use efficient algorithms (Dong and Li, 1999; Li, 2001; Li et al., 2000) to discover EPs based on the discretized data. The EPs are combinations of intervals of gene expression levels of these relevant genes. The EPs that are discovered are maximally frequent in one class of data but do not occur in the other class. The discovered EPs always contain only a small number of the relevant genes. This result reveals interesting conditions on the expression of these genes that differentiate between two classes of data. Third, each EP with high frequency is considered as a common property of a class of cells and, based on this idea, we propose a strategy for treating colon tumors by adjusting the expression level of some improperly expressed genes. We show later that almost all 'adjusted' cells are predicted as normal cells by a number of good classifiers that were trained to distinguish between normal vs colon tumor cells.
The remainder of this paper is organized as follows. We begin with a brief introduction to the concept of emerging patterns (Dong and Li, 1999) . Then we describe a method (Fayyad and Irani, 1993) to discretize continuous features (attributes). Then we present our main results on the colon tumor dataset, including the discretization results, the EP discovery results, the classification accuracy, and a treatment plan for curing the disease. Then we provide the discovered patterns from the ALL/AML dataset. Finally we conclude this paper. 
EMERGING PATTERNS
A pattern always has a frequency in a dataset. We use an example to show how to calculate the frequency of a pattern. (Dong and Li, 1999; Li, 2001; Li et al., 2000) .
AN ENTROPY-BASED DISCRETIZATION METHOD
One challenge of gene expression data to data mining algorithms is the large number of genes involved. This work introduces a discretization method (Fayyad and Irani, 1993) that makes use of the heuristic of entropy minimization. As discussed earlier, the method automatically removes many noisy features (genes) and effectively explores the remaining most discriminatory features.
We follow the notation presented in Dougherty et al. (1995) and Fayyad and Irani (1993) . Let T partition the set S of examples into the subsets S 1 and S 2 . Let there be
The class entropy of a subset S j , j = 1, 2 is defined as:
Suppose the subsets S 1 and S 2 are induced by partitioning a feature A at point T . Then, the class information entropy of the partition, denoted E(A, T ; S), is given by:
A binary discretization for A is determined by selecting the cut point T A for which E(A, T ; S) is minimal amongst all the candidate cut point (Fayyad and Irani, 1993) . The same process can be applied recursively to S 1 and S 2 until some stopping criteria is reached.
The Minimal Description Length Principle is used to stop partitioning (Fayyad and Irani, 1993) . Recursive partitioning within a set of values S stops iff
where N is the number of values in the set S,
and k i is the number of class labels represented in the set S i . Note that this method is resistant to the effect of data normalization (e.g. taking logarithm) provided that the normalization does not change the order of the original values. The method has been implemented by MLC++ techniques (Kohavi et al., 1994) . The executable codes are available at http://www.sgi.com/tech/mlc/.
RESULTS ON THE COLON TUMOR DATASET
We next report the discretization results on the colon tumor dataset to see which genes are selected and which genes are discarded. Then, we present our important results-the emerging patterns together with their frequency. We then discuss how the expression scale of every single gene shifts between normal and cancer tissues. Based on the discovered EPs, we also suggest a therapy for treating the colon tumor patients.
Discretization results
The discretization method partitions 35 of the 2000 genes each into two disjoint intervals, while there is no cut point in the remaining 1965 genes. This indicates that only 35/2000 = 1.75% of the genes are considered as the most discriminatory genes and the others can be considered as irrelevant indicators. By deriving a small number of good diagnostic indicator genes, the discretization method lays down a foundation for us to efficiently discover reliable emerging patterns. Otherwise, a large number of noisy patterns would be generated.
The discretization result is summarized in Table 2 . The first column is our index of the genes, the second column shows the gene accession numbers, the third column presents the intervals of gene expression levels, followed by the gene's name at column 4. Note that there are a total Recall that an item is a pair where a gene is linked with an interval. We index the 70 items. The first gene's two intervals are indexed as the 1st and 2nd items, · · ·, the ith gene's two intervals as the (i * 2 − 1)th and (i * 2)th items, · · ·, the 35th gene's two intervals as the 69th and 70th items. This index is convenient to read and write emerging patterns; for example, the pattern {2} represents {gene T 51560 @[101.3719, +∞)}.
Discovered emerging patterns
The EPs are discovered by two efficient border-based algorithms, BORDER-DIFF and JEPPRODUCER (Dong and Li, 1999; Li, 2001; Li et al., 2000) . They do not need to conduct an exhaustive enumeration of EP candidates. With borders, a concise representation tool, the algorithms do not need to output all EPs but only the most frequent ones from which the others can be derived. According to our experimental studies, the algorithms are linearly scalable 19 86.36 0 to the size of samples, and linearly scalable to the number of features approximately. A total of 19,501 EPs that have a non-zero frequency in the normal tissues of the colon tumor dataset were discovered. A total of 2165 EPs that have a non-zero frequency in the cancer tissues were derived by our algorithms.
Tables 3 and 4 present, in terms of frequencies, the top 20 EPs which occur in the 22 normal tissues, and the top 20 EPs which occur in the 40 cancer tissues. Column 1 shows the emerging patterns. The numbers in the patterns, for example 16, 58, and 62 in the pattern {16 58 62}, stand for the items just discussed and indexed.
Computationally, we explain the emerging patterns as follows:
• Some of the emerging patterns are very interesting because they contain a relatively large number of genes. For example, the pattern {2 3 6 7 13 17 33} combines 7 genes together and still has a very large frequency (90.91%) in the normal tissues. Almost every normal cell's expression values satisfy all of the conditions implied by these 7 items. However, no single cancer cell satisfies all the conditions. By definition (see the section on Emerging patterns), all of the proper sub-patterns of the pattern {2 3 6 7 13 17 33}, including singletons and the combinations of six items, must have a non-zero frequency in both of normal and cancer tissues. This means that there must exist at least one cell from both of normal and cancer tissues satisfying the conditions implied by any subpatterns of {2 3 6 7 13 17 33}.
• The frequency of a singleton emerging pattern is not necessarily larger than emerging patterns containing more than one item. For example the pattern {5} is an emerging pattern in cancer cells with a frequency of 32.5%. Comparing with the frequency (75%) of the pattern {16 58 62}, the frequency of {5} is about 2.3 times less. This indicates that, for the analysis of gene expression data, groups of genes and their correlations are better and more important than single genes.
• Without the discretization method and the borderbased EP discovery algorithms, it is very hard to discover these reliable emerging patterns with large frequencies. Assume the 1965 genes are each partitioned into two intervals as well, then there are C 7 20 * 2 7 possible patterns having a length of 7. The enumeration of so huge a number of patterns and the calculation of their frequencies is definitely impossible. Even with the discretization method, the naive enumeration of C 7 35 * 2 7 patterns is still too expensive for discovering the pattern {2 3 6 7 13 17 33}. Furthermore, some of the discovered EPs (not listed here) contain more than 7 genes. Through the use of the two border-based algorithms, only those EPs whose proper subsets are not emerging patterns are discovered. We can derive other EPs using the discovered EPs. Generally, any proper superset of a discovered EP is also an emerging pattern. For example, using the EPs with the count of 20 (shown in Table 3 ), we can derive a very long emerging pattern, {2 3 6 7 9 11 13 17 23 29 33 35}, consisting of 12 genes, with the same count of 20. Furthermore, the border-based algorithms are guaranteed to discover all the emerging patterns.
Note that any one of the 62 tissues must match at least one emerging pattern from its own class, but never contain any EPs from the other class. So, our system has well learned the whole data.
Gene expression trends
Next, we answer the question of which genes change their expression level significantly between normal and tumor tissues. We first look for those genes whose expression in normal and cancer tissues are two-end polarized. However, this ideal case does not happen to the colon tumor dataset. So, for any single gene, there does not exist any cut point such that the resulting two intervals contain pure-class points. (Observe that if an interval contains pure-class points, then it must be an EP.) Sub-optimally, we search for genes which have two intervals containing almost pure-class points.
Using Table 5 , we report the cut point for every gene's expression level range and the coverage of the intervals. By the coverage of an interval, we mean the number of samples from both normal and cancer tissues that are covered by the interval. In the 8th column of Table 5 , we provide the entropy of every gene's range when a cut point is inserted. By definition, the smaller the entropy is, the more discriminatory the gene is. For the ideal case where two intervals cover only pure-class points, the gene's entropy is 0.
From Table 5 Similarly, let us examine the 22nd gene, X12671, which has the second lowest entropy among the 35 genes. Neither its left interval nor its right interval covers pure-class In summary, there is no single gene that acts as an arbitrator to distinguish the normal and cancer cells. However, genes with lower entropies can be considered as good diagnostic markers. We next consider gene groups and use those highly frequent emerging patterns for planning a treatment strategy.
A treatment plan
The basic idea of the treatment plan is to increase or decrease the expression levels of some particular genes in a cancer cell, so that it has the common properties of normal cells. As a result, instead of killing it, the cancer cell is 'converted' into a normal one.
As shown in Table 3 , the frequency of emerging patterns can reach a very high level such as 90%. The conditions implied by a highly frequent EP form a common property of one class of cells. Using the EP {2 3 6 7 13 17 33} again, we have understood that each of the about 91% of normal cells expresses the seven genes (T51560, T49941, M62994, R34701, L02426, U20428, and R10707) in such a way that the seven expression levels are one-to-one contained in the seven intervals (the 2nd, 3rd, 6th, 7th, 13th, 17th, and 33rd intervals as shown in Table 2) . Although a cancer cell may express some of the seven genes in a similar manner as normal cells do, according to the dataset, a cancer cell can never express all of the seven genes in the same way as normal cells do. So, if the expression levels of those improperly expressed genes can be adjusted, the cancer cell can be made to have one common property that normal cells exhibit. A cancer cell can then be iteratively converted into a normal one. As there usually exist some genes of a cancer cell which express in a similar way as their counterparts in normal cells, less than 35 genes' expression levels are required to be changed. The most important issue is to determine which genes need an adjustment. Our EPs can be used to address this issue. We use a cancer cell (T1) of the colon tumor dataset as an example to show how a tumor cell is converted into a normal one. Firstly, we list the expression profile of 7 genes of T1: Expression 1148.16 364.34 467.61 290.80 140.64 197.32 178.15 Note that about 91% (20 out of 22 cases) of the normal cells have the following expression intervals for these 7 genes:
Gene T51560 T49941 M62994 R34701 L02426 U20428 R10707 Intervals [101.37, [94.40, +∞) 272.54) +∞) 446.03) 390.61) 207.80) 378.80) Comparing T1's gene expression levels with the intervals of normal cells, we see that only T49941 of the 7 genes of the cancer cell T1 behaves in a different way from those the 22 normal cells commonly express. Namely, 364.34 is beyond the interval (−∞, 272.54). However, the rest of the 7 genes of T1 are in the same expression range as most of the normal cells. So, if the gene T49941 of T1 can be down-regulated to scale below the gate point 272.54, then this adjusted cancer cell will have a common property of normal cells. This is because {2 3 6 7 13 17 33} is an emerging pattern which does not occur in cancer cells. This idea is at the core of our suggestion for a treatment plan. Interestingly, the expression change of the gene T49941 in T1 leads to a chain of other changes. These include the change that two extra top-ten EPs of normal cells are contained in the adjusted T1. So a total of three top-ten EPs of normal cells are contained in T1 if the gene T49941's expression level is adjusted. Similarly, after scaling the gene X62153's expression level to below 395.25 and the gene T72403's expression level below 296.57, T1 will contain 9 top-ten EPs of the normal cells. As the average number of top-ten EPs contained in normal cells is 9, the changed T1 cell will now be considered as a cell that has the most important features of normal cells. Note that we have adjusted only three genes' expression level so far.
We also need to eliminate those common properties of cancer cells that are contained in T1. By adjusting the expression level of another six genes (K03001, T49732, U29171, R76254, D31767, L40992), the top-ten EPs of cancer cells all disappear from T1. (Typically, the average number of top-ten EPs of cancer cells contained in a cancer cell is 6.) Therefore, T1 is converted into a normal cell as it is now holding the common properties of normal cells and does not include the common properties of cancer cells.
By this method, all the other 39 cancer cells can be converted into normal ones after adjusting the expression levels of 10 genes or so, possibly different genes from person to person. We conjecture that this personalized treatment plan is effective if the expression of some particular genes can be modulated by suitable means.
We next discuss a validation of this idea. The 'adjustments' we made to the 40 colon tumor cells were based on the emerging patterns in the manner described above. If these adjustments had indeed converted the colon tumor cells into normal cells, then any good classifier that could distinguish normal vs colon tumor cells on the basis of gene expression profiles would classify our adjusted cells as normal cells. The widely-used Support Vector Machine (SVM) is a powerful tool for prediction tasks. We thus established an SVM model using original data from the 62 (22 normal plus 40 cancer) cells as training data. (The code for constructing an SVM model is available at http://www.cs.waikato.ac.nz/ml/weka.) Then the emerging pattern-based method described earlier was used to adjust the expression levels of particular genes in the cancer cells. Then, the 40 adjusted cancer cells were fed to the model. The outcome was that all of the adjusted cells were predicted as normal cells. Though our 'therapy' was not applied to the real treatment of a patient, the prediction result by the SVM model partially demonstrates the potential biological significance of our proposal.
There are other good classification algorithms that could be obtained at http://www.cs.waikato.ac.nz/ml/weka. We also tried C4.5, HyperPipes (HP), and Voting Feature Intervals (VFI) to predict the class of the converted cells. C4.5 predicted 32 of the 40 converted cells as normal and the remaining 8 still as cancer cells. The HP classifier and the VFI classifier both predicted 39 converted cancer cells as normal and the remaining one cell still as cancer. These results are very close to that of the SVM model. Note that the SVM model, the HP classifier, and the VFI classifier all have good performance on the training data (6, 5, and 3 mistakes respectively).
Usefulness of the EPs in classification
In this section, we test the usefulness of EPs in classification by conducting a Leave-One-Out-Cross-Validation (LOOCV) application. By LOOCV, we pick up the first instance of the 62 tissues as a test instance, and the remaining 61 instances as training data. Repeating through the first instance to the 62nd one, we can finally get an accuracy, the percent of the instances which are correctly predicted.
For a given test instance, denoted tInstance, and its corresponding training data D, our method consists of the following steps for predicting the class of tInstance:
(1) Divide D into two sub-datasets, denoted D n and D c , respectively consisting of the normal training tissues and the cancer training tissues.
(2) Discover the EPs in D n , and similarly discover the EPs in D c . (3) According to the frequency and the length (the number of items in a pattern), sort the EPs (from both D c and D n ) into a descending order. The ranking criteria are:
(a) Given two EPs X i and X j , if the frequency of X i is larger than X j , then X i is prior to X j in the list. (b) When the frequency of X i is equal to X j , if the length of X i is longer than X j , then X i is prior to X j in the list. (c) We treat the two patterns equally when their frequency and length are both identical.
Denote the ranked EP list as orderedEPs.
(4) Put the first EP of orderedEPs back into finalEPs. We correctly predict 57 of the 62 tissues. Only three normal tissues (N1, N2, and N39) were wrongly classified as cancer tissues, and two cancer tissues (T28 and T33) were wrongly predicted as normal tissues. We compare this result with a result in the literature. Furey et al. (2000) mis-classified six tissues (T30, T33, T36, N8, N34, and N36), using 1000 genes and an SVM approach. Interestingly our mis-classified examples almost differ from those mis-classified by the SVM method. (T33 was commonly mis-classified.) It can be seen that the classification performance of our method is better than the SVM method (Furey et al., 2000) though we used a much smaller number of genes. Another advantage is that our method can provide easily understandable patterns rather than a 'black box' embedded in the SVM model.
RESULTS ON THE ALL/AML DATASET
Next, we apply our method to the ALL/AML dataset. Using the discretization method, 866 of the 7129 features in the 38 training data are partitioned into two or three intervals; there is no cut point in the rest of the features. So, there are 6263 discarded features. Generally, the availability of such a large number of multi-interval features implies that it is easy to separate the two classes of samples.
We examined the 866 features and found that gene Zyxin has an entropy of 0 when the cut point is set as 994. This indicates that the expression of Zyxin in all the 27 ALL samples is less than 994, but the expression of Zyxin in all the 11 AML samples is equal to or larger than 994. So the gene Zyxin can be used solely by itself as an arbitrator to make a clear distinction between the 38 ALL and AML samples. We note that the two intervals associated with Zyxin form two EPs, each having 100% frequency in the two classes. We also found many other EPs with 100% frequency. All of these EPs with 100% frequency are arbitrators to distinguish ALL and AML samples.
To show a further potential of our EPs in classification, we again use the one gene, Zyxin, to predict the class of the 34 testing samples (Golub et al., 1999) . The rule is that if the expression of Zyxin of a cell is less than 994, then this cell is an ALL sample. Otherwise it is an AML sample. We correctly classified 31 samples, but misclassified 3 (one AML, the 31st sample; two ALL, the 15th and 17th samples). This result is better than or comparable to several results reported in the literature (Golub et al., 1999; Furey et al., 2000) where at least dozens even thousands of genes were used. This comparison is summarized in Table 6 .
DISCUSSION
The essence of the new concept of emerging patterns is to distinguish two classes of things. This concept has shown great potential to discover differences from the expression profile of two types of cells, and it can be extended to more than two types of cells. Particularly interesting patterns Table 6 . The accuracy comparison of our method vs a SVM method (Furey et al., 2000) vs a clustering method (Golub et al., 1999) are those with six, seven, or even 12 genes and with a very large frequency. Even with only one or two of the patterns, the normal vs colon tumor tissues or the ALL vs AML samples can be totally distinguished. In this study, the EPs are ranked based on their frequency. We plan to investigate in future the interestingness of EPs based on their neighborhood frequency fluctuation (Dong and Li, 1998) or other types of measurements (Golub et al., 1999) .
Gene expression values are always continuous and the number of genes involved is very large. An important problem in the discovery of EPs is how to discretize data and how to select a few number of diagnostic features. The entropy-based discretization method can automatically ignore most of the genes if their expression are randomly distributed in a range. In the field of machine learning, there are many other optional methods for feature selection. It is interesting to see whether those methods work for expression data.
In addition, commonly in real life only as few as 3 or 4 patient samples are available per class. Many prediction models are greatly affected by small numbers of training samples. Fortunately, the dataset used in this study is relatively large and our classification model works well. We would like in future to study how robust our method is in terms of the size of training data.
The proposed treatment plan is a personalized therapy. The idea is to modify the expression of some specific genes such that a cancer cell can hold many common properties of normal cells but contain few EPs of cancer cells. Consequently, the cancer cell is converted into a normal one. Eventually, this plan should be confirmed by biological and medical experiments or treatments. However, an effective means for identifying the mechanisms and pathways through which to modulate the expression of selected genes needs to be developed first.
